2 ASX 200 shares with enough pricing power to battle inflation: Expert

An expert has tipped Transurban and Resmed shares as potential inflation safe havens.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Rising inflation has been the talk of the town in 2022 and S&P/ASX 200 Index (ASX: XJO) shares aren't immune from its bite.

In fact, many ASX 200 technology shares have been hit hard by the shifting landscape. The S&P/ASX 200 Information Technology Index (ASX: XIJ), for example, has plunged nearly 38% year to date.

So, which ASX 200 shares can investors trust to grow their hard-earned money in 2022?

Head of Australian equities at T. Rowe Price, Randal Jenneke has flagged two stocks he believes have plenty of pricing power and could act as inflation hedges.

A woman sits in contemplation with superimposed images of piles of gold coins, graphs, and star-like lights above her head as though she is thinking about investment options.

Image source: Getty Images

2 ASX 200 shares to buy in times of inflation

There are two likely ways Australia's current inflationary environment could shift, according to Jenneke.

The first – and most unlikely direction – is towards 1970s-style "stagflation". The more likely happening? Inflation continuing to rise through 2022. 

"The challenge of rising costs, whether labour or other inputs, will likely persist and contribute to higher headline inflation over the rest of the year," Jenneke said.

"[W]e will likely see investor focus shift more from top line revenue growth to margin sustainability and their volatility. We have already seen the valuation gap between high margin and high growth narrow."

And companies with strong pricing power are the most prepared to manage through such a period.

"To pass on costs effectively to buyers requires a good industry structure, differentiated products, and defensive volumes," Jenneke said.

Resmed CDI (ASX: RMD)

Fortunately, ASX 200 healthcare share Resmed has just that. Jenneke said:

Resmed … has a large under-penetrated market, and despite various input and logistics cost pressures, has been able to pass through price increases given their dominant market share and current lack of reputable competition.

The Resmed share price is currently $30.91, 14.5% lower than it was at the start of 2022.

Transurban Group (ASX: TCL)

ASX 200 infrastructure share Transurban is also set up to battle inflation, according to Jenneke, who said:

Transurban … has built-in price increases for its contracts.

The nature of its cost structure brings high [earnings before interest and tax (EBIT)] margins and margin stability. Anecdotally, you know the cost of tolls are rising when every second taxi driver makes a point or two about it.

The Transurban share price is $14.45 right now, having gained 3.6% year to date.

Finally, the expert noted, "while these are two [shares] we like, we should stress our views are supported by our fundamental insights, rather than the broader economic climate."

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Broker Notes

Up 170% in a year: Are Codan shares a buy?

Investors have more than doubled their money in 12 months with this stock.

Read more »

A person leans over to whisper a secret to a colleague during a meeting.
Broker Notes

Bell Potter is tipping this ASX All Ords share as a buy with 15% upside

Let's see which share the broker is recommending to clients.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Fortescue shares: Buy, hold, or sell? Bell Potter gives its verdict

Let's see what the broker is saying about this mining giant.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Karoon Energy and Santos shares

A leading analyst delivers his verdict on Karoon Energy and Santos shares.

Read more »

An older woman gazes over the top of her glasses with a quizzical expression as if she is considering some information.
Broker Notes

Is this ASX 200 stock a buy, hold or sell after rising 15% year to date?

Can this high-performing stock keep rising?

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

Macquarie names 3 ASX shares to buy

Two miners and a packaging company are on the broker's list of stocks to watch.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Broker Notes

Are these ASX shares a buy, hold or sell according to Morgans after key updates?

Here's the latest guidance from Morgans.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »